Plédran, France

Pierre Le Cann

USPTO Granted Patents = 29 

 

Average Co-Inventor Count = 10.0

ph-index = 17

Forward Citations = 1,049(Granted Patents)


Location History:

  • Pléran, FR (2006)
  • Pledran, FR (2007 - 2008)
  • Plédran, FR (2004 - 2018)

Company Filing History:


Years Active: 2004-2018

Loading Chart...
Loading Chart...
29 patents (USPTO):Explore Patents

Title: Pierre Le Cann: Innovator in Veterinary Medicine

Introduction

Pierre Le Cann, based in Plédran, France, is a prominent inventor with an impressive portfolio of 29 patents. His innovative work primarily focuses on veterinary medicine, specifically addressing challenges related to piglet health and viral infections.

Latest Patents

Among his latest contributions, Le Cann has developed a series of patents encompassing genome sequences and nucleotide sequences related to the circovirus associated with piglet weight loss disease (PWD). These patents detail the structural and non-structural polypeptides of the virus, along with vectors that include these sequences, and the cells and animals transformed by these vectors. His work also involves methods for detecting nucleic acids or polypeptides of the circovirus, as well as diagnostic kits for identifying infections caused by this virus. Additionally, he has devised methods for selecting compounds that can modulate viral infections, and he has formulated pharmaceutical compositions, including vaccines, aimed at preventing and treating PWD.

Career Highlights

Pierre Le Cann has had a distinguished career, having worked with renowned companies in the pharmaceutical and veterinary sectors, including Wyeth and Zoetis LLC. His contributions to these organizations have significantly advanced the understanding and management of viral infections in livestock.

Collaborations

In his career, Le Cann has collaborated with esteemed colleagues such as Emmanuel Albina and Philippe Blanchard. These collaborations have fostered innovation and furthered research in veterinary medicine, enhancing the development of effective treatments for livestock diseases.

Conclusion

Pierre Le Cann's dedication to innovation in veterinary medicine is evident through his extensive patent portfolio and impactful collaborations. His research on circovirus and its implications for piglet health represents a significant advancement in protecting livestock from viral diseases, ensuring better outcomes for the agricultural industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…